Document is current
Any future updates will be listed below
-
Authors
Burgos, Jose Luis
Cepeda, Javier A. http://orcid.org/0000-0003-0304-3172
Kahn, James G.
Mittal, Maria Luisa
Meza, Emilio
Lazos, Raúl Rafael Palacios
Vargas, Psyché Calderón
Vickerman, Peter
Strathdee, Steffanie A.
Martin, Natasha K.
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (R01DA037773, K01DA043421, T32DA023356)
Fogarty International Center (R25TW009343)
National Institute of Allergy and Infectious Diseases (P30AI036214)
- License Information
-
More Information
Article History
Received: 3 March 2018
Accepted: 13 May 2018
First Online: 23 May 2018
Ethics approval and consent to participate
: The study was approved by the Institutional Review Boards of UCSD School of Medicine and Universidad Autónoma de Baja California, Mexico.
: NM has received unrestricted research grants from Gilead unrelated to this work and honoraria from Gilead and Merck. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
